Glycosidase
Glycosidase
Glycosidase are a class of enzymes which catalyze the hydrolysis of glycosidic bonds. In living organisms, Glycosidase are involved in carbohydrate metabolism. They can degrade polysaccharides such as starch and glycogen into monosaccharides, providing energy for cells. Glycosidase also participate in the synthesis and modification of biological macromolecules such as glycoproteins and glycolipids, playing a crucial role in cell recognition and signal transduction. Additionally, in plants and microorganisms, Glycosidase are involved in the metabolism of cell wall polysaccharide components, affecting cell growth, differentiation, and morphogenesis. Gene mutations of Glycosidase can trigger genetic diseases, leading to abnormal metabolism in the body and damage to organ functions. Changes in their activity are associated with various diseases such as diabetes, infectious diseases, and tumors, and can influence the occurrence and development of diseases[1][2].
References:
- [1]. Wang X, et al. Metabolites extracted from microorganisms as potential inhibitors of glycosidases (α-glucosidase and α-amylase): A review. Front Microbiol. 2022 Nov 17;13:1050869.
- [2]. Ohtsubo K, et al. Glycosylation in cellular mechanisms of health and disease. Cell. 2006 Sep 8;126(5):855-67. [Content Brief]
All Product Categories
-
Glycosidase Inhibitors
(448)
View all products
-
Glycosidase Antagonist
(1)
View all products
-
Glycosidase Activators
(20)
View all products
-
Glycosidase Modulators
(8)
View all products
-
Glycosidase Chemical
(1)
View all products
-
Glycosidase Inducers
(2)
View all products
-
Glycosidase Degrader
(1)
View all products
-
Glycosidase Controls
(5)
View all products
-
Glycosidase Substrates
(23)
View all products
-
Glycosidase Ligands
(3)
View all products
-
Glycosidase Related Products (688)
Related Products (688)
-
Antibodies (3)
-
Clervonafusp alfa
0 ImagesCat. No.: HY-P99803CAS No.: 2145123-44-8Synonyms: VAL-1221Clervonafusp alfa (VAL-1221) is a fusion protein targeting both cytosolic and lysosomal glycogen. Clervonafusp alfa is comprised of the Fab portion of a cell-penetrating antibody and recombinant human acid alpha glucosidase (rhGAA), the former utilizing the nucleoside transporter ENT-2 to gain access to the cytosol, and the latter enters lysosomes via mannose-6-phosphate receptors (M6PRs). Clervonafusp alfa can be used for late-onset Pompe disease research.
-
α-Glucosidase-IN-121
0 ImagesCat. No.: HY-187377α-Glucosidase-IN-121 is a yeast α-glucosidase inhibitor with an IC50 of 3.8 μM and a Ki of 12.9 μM. α-Glucosidase-IN-121 binds to the active site of the enzyme, competes with substrate binding, and forms stable interactions with Phe137, Ser308, Pro309, Arg312 and Glu350 via hydrogen bonding, π-π stacking and hydrophobic interactions. α-Glucosidase-IN-121 can be used in the research of diabetes.
-
α-Glucosidase-IN-74
0 ImagesCat. No.: HY-169117α-Glucosidase-IN-74 (Compound 7d), an isatin-thiazole derivative, is a α-glucosidase inhibitor. α-Glucosidase-IN-74 exhibits antidiabetic activity by decreasing glycaemia and triglyceride levels in Streptozotocin (HY-13753)-induced diabetic animals.
-
Salacinol
0 ImagesCat. No.: HY-119741CAS No.: 200399-47-9Salacinol, compound found in Salacia reticulata, is an orally active α-glucosidase/lipase inhibitor. Salacinol inhibits enzymatic activity of intestinal maltase (IC50 = 3.2 μg/mL, Ki = 0.31 μg/mL), sucrase (IC50 = 0.84 μg/mL, Ki = 0.32 μg/mL), and isomaltase (IC50 = 0.59 μg/mL, Ki = 0.47 μg/mL), and inhibits increases in serum glucose levels in sucrose-loaded rats. Salacinol also inhibits pancreatic lipase and lipoprotein lipase. Salacinol can be used for the research of diabetes mellitus.
-
2-Nitrophenyl a-D-glucopyranoside
0 ImagesCat. No.: HY-148672CAS No.: 56193-44-32-Nitrophenyl a-D-glucopyranoside is a substrate of β-glucosidase.
-
Glycosidase-IN-1
0 ImagesCat. No.: HY-135670CAS No.: 170376-12-2Glycosidase-IN-1 (Compound 9) is a glycosidase inhibitor synthesized from D-mannose. Glycosidase-IN-1 be used to synthesize some immunosuppressive agents and β-glucosidase inhibitors. Glycosidase-IN-1 has hypoglycemic activity.
-
α-Glucosidase-IN-10
0 ImagesCat. No.: HY-147965CAS No.: 2586282-68-8α-Glucosidase-IN-10 (compound 13) is a potent α-glucosidase inhibitor, with an IC50 of 92.7 μM. α-Glucosidase-IN-10 can be used for type II diabetes research.
-
Bisabolone oxide A
0 ImagesCat. No.: HY-N8120CAS No.: 22567-38-0Bisabolone oxide A is an α-glucosidase inhibitor.
-
ToP-DNJ
0 ImagesCat. No.: HY-125426CAS No.: 1508303-85-2ToP-DNJ is a selective endoplasmic reticulum α-glucosidase II (GluII) inhibitor with an IC50 value of 9.0 μM. ToP-DNJ selectively inhibits the two catalytic reactions of GluII, and exhibits stronger activity in the first step of converting di-glycosylated glycans to mono-glycosylated glycans. ToP-DNJ exhibits anti-DENV activity. ToP-DNJ can be used in studies related to dengue virus infection.
-
CHI3L1-IN-6
0 ImagesCat. No.: HY-180937CAS No.: 1914772-75-0CHI3L1-IN-6 (Compound 9e) is a CHI3L1 inhibitor with a Kd of 19.11 μM for hCHI3L1. CHI3L1-IN-6 blocks CHI3L1-Galectin-3 interaction. CHI3L1-IN-6 reduces STAT3 signaling. CHI3L1-IN-6 exhibits anti-cancer activity against glioblastoma.
-
Lysosomal α-Glucosidase
0 ImagesCat. No.: HY-E70183Synonyms: EC:3.2.1.20; GAALysosomal α-Glucosidase (EC:3.2.1.20) is a lysosomal α-Glucosidase that degrades glycogen into glucose and catalyzes the hydrolysis of α-1,4 and α-1,6 glycosidic linkages in glycogen, as well as that of natural and synthetic oligoglucosides. Deficiency of Lysosomal α-Glucosidase causes type II glycogen storage disease (Pompe disease), which is characterized by lysosomal glycogen accumulation in mammals and birds. Lysosomal α-Glucosidase can be used in research related to type II glycogen storage disease.
-
[8]-Dehydrogingerdione
![[8]-Dehydrogingerdione](https://file.medchemexpress.com/product_pic/hy-n19646.gif "Click to View [8]-Dehydrogingerdione Product Detail")
0 ImagesCat. No.: HY-N19646CAS No.: 77334-08-8[8]-Dehydrogingerdione is a Hydroxyphenylalkanone. [8]-Dehydrogingerdione can be isolated from the seeds of Aframomum melegueta and the rhizomes of Curcuma xanthorrhia. [8]-Dehydrogingerdione acts as an inhibitor of α-glucosidase and Tyrosinase, with an IC50 value of 19.5 μM against α-glucosidase and an approximate IC50 value of 100 μM against tyrosinase. [8]-Dehydrogingerdione can be used in diabetes-related research.
-
α-Glucosidase-IN-94
0 ImagesCat. No.: HY-174840α-Glucosidase-IN-94 (Compound 6e) is a potent α-glucosidase inhibitor with an IC50 value of 0.1412 mM. α-Glucosidase-IN-94 is promising for research of type 2 diabetes.
-
Trehalose-6-phosphate hydrolase, Bacillus subtilis
0 ImagesCat. No.: HY-E70898ATrehalose-6-phosphate hydrolase, Bacillus subtilis (EC 3.2.1.93), belongs to the hydrolase family and is a glycosidase that hydrolyzes O- and S-glycoside compounds. Trehalose-6-phosphate hydrolase participates in the metabolism of starch and sucrose. Its substrates are α,α'-trehalose-6-phosphate and water, and its products are D-glucose and D-glucose-6-phosphate.
-
Endoglycosidase CC
0 ImagesCat. No.: HY-E70880ASynonyms: EndoCCEndoglycosidase CC (EndoCC), an endoglycosidase, is a substrate of glycopeptide.
-
α-Glucosidase-IN-17
0 ImagesCat. No.: HY-151141CAS No.: 2820424-84-6α-Glucosidase-IN-17 (Compound 12B) is a potent, orally active α-glucosidase inhibitor with an IC50 of 3.79 μM. α-Glucosidase-IN-17 shows antidiabetic activity.
-
Antidiabetic agent 5
0 ImagesCat. No.: HY-161429CAS No.: 2152667-21-3Antidiabetic agent 5 (compound S1) is a antidiabetic agent. Antidiabetic agent 5 inhibits the activity of α-glucosidase and α-amylase with IC50 values of 3.91，8.89 μM，respectively. Antidiabetic agent 5 decreases sugar levels. Antidiabetic agent 5 has the potential for the research of type-II diabetes.
-
α-Glucosidase-IN-21
0 ImagesCat. No.: HY-151145CAS No.: 321686-01-5α-Glucosidase-IN-21 (Compound 2B) is a potent, orally active α-glucosidase inhibitor with an IC50 of 2.62 μM. α-Glucosidase-IN-21 shows anti-diabetic activity.
